Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

A Prospective, Observational Study To Monitor Safety In Patients Who Were Administered With Tigecycline (Tygacil) 50 mg By Intravenous Injection (An Observational Study for Safety - Monitored Release)

The purpose of this study is to collect post-marketing information on the safety of Tygacil in Filipino patients.

Three-thousand or 10% of total number of patients given tigecycline will be included in the study

Inclusion Criteria:

• All patients from the study center who received or will receive at least one dose of Tygacil according to the approved product indication.

Exclusion Criteria:

• Previously discontinued Tygacil therapy due to significant safety concern.